Xiaofeng Hu, M.D., Ph.D., FACMG

Cytogenetics Laboratory Director

  • Board-certified: Clinical Cytogenetics by the American Board of Medical Genetics
  • Ph. D. from Erasmus University/National Ophtalmic Research Institute, The Netherlands
  • M.S. from Tongji Medical University, China. Here thesis was the Study on DNA replication in structural abnormality of the X chromosome.
  • M.D. from Tongji Medical University, China.
  • Prior to joining ProPath, Dr. hu was the Clinical Director of Sonora Quest Lab for four years.
  • In 2016, she became Scientific Director of Cytogenetics for TriCore Reference Lab, New Mexico.
  • Join ProPath in 2017.